
Fresenius
FSNUY | OTC
$14.79
-$0.01 (-0.07%)
At close: Nov 16, 2026, 3:53 PM ET
$14.81
+$0.02 (+0.14%)
After-hours:
Nov 16, 2026, 3:50 PM ET
Fresenius Company Profile
Company profile explainedCompany Profile
Fresenius SE & Co. KGaA is a healthcare group, which engages in the provision of products and services for dialysis, hospitals, and outpatient medical care. It operates through the following segments: Fresenius Medical Care, Fresenius Kabi, Fresenius Helios and Fresenius Vamed. The Fresenius Medical Care segment caters to individuals with renal diseases. The Fresenius Kabi segment specializes in lifesaving medicines and technologies. The Fresenius Helios offers expertise in inpatient and outpatient care as well as in telemedicine. The Fresenius Vamed segment manages projects and services for hospitals and other healthcare facilities. The company was founded by Eduard Fresenius on October 1, 1912 and is headquartered in Bad Homburg, Germany.
Key Executives
| Name | Position |
|---|---|
| Michael Sen | Chief Executive Officer, President & Chairman of Management Board of Fresenius Management SE |
| Pierluigi Antonelli | Member of Management Board of Fresenius Management SE & Chief Executive Officer of Fresenius Kabi |
| Sara Hennicken | Chief Financial Officer & Member of the Management Board - Fresenius Management SE |
| Christian Pawlu | Member of Management Board |
| Michael Sven Moser | Member of the Management Board of Fresenius Management SE |
| Nick Stone | Senior Vice President of Investor Relations & Head of Investor Relations - Fresenius Management SE |
Fresenius

| Country | Germany |
| IPO Date | May 15, 2012 |
| Industry | Medical - Care Facilities |
| Sector | Healthcare |
| Employees | 178,394 |
| CEO | Michael Sen |
Contact Details
Else-Kroener-Strasse 1 Bad Homburg vor der Höhe,
HE 61352 Germany
Stock Details
| Ticker Symbol | FSNUY |
| Exchange | OTC |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0000904868 |
| CUSIP Number | 35804M105 |
| ISIN Number | US35804M1053 |
| SIC Code | 3841 |
Recent News
- 13 days ago / seekingalpha.comFresenius SE & Co. KGaA (FSNUY) Q3 2026 Earnings Call Transcript
- 2 months ago / zacks.comAre Investors Undervaluing Fresenius SE & Co. (FSNUY) Right Now?
- 2 months ago / prnewswire.comWaltz Health and Fresenius Kabi Expand Direct Access to Biosimilars Through Waltz Connect Platform
- 2 months ago / zacks.comShould Value Investors Buy Fresenius SE & Co. (FSNUY) Stock?
Add to Watchlist
Select watchlists to add or remove FSNUY